Supply of Fluticasone Propionate Inhaler HFA

The contract pertains to the procurement and delivery of 30 units of Fluticasone Propionate Inhaler HFA, identified by NSN 6505015326924, to meet federal medical supply requirements. This subcontract, issued under the Defense Logistics Agency within the Department of Defense, ensures that the inhalers are manufactured and delivered in full compliance with established standards for federal medical equipment. The procurement is scoped specifically to fulfill a targeted need within the defense medical supply chain, with no set-aside provisions or small business designations applied. The contract was posted on July 14, 2026, and is referenced under the award number SPE2DX25D9900 with delivery identified under SPE2DP26F7645. The North American Industry Classification System code 325412 indicates that the supplier operates within the pharmaceutical and medicine manufacturing sector. While no specific delivery location or point of contact is provided, the terms require full adherence to federally mandated medical supply protocols, ensuring the product’s safety, efficacy, and traceability throughout the distribution process. The electronic record is accessible via the DIBBS system for verification and tracking purposes.